Summary Sarah Cannon Research Institute LLC (SCRI) is a research institute that offers integrated cancer services.The institute conducts clinical research programs for advancing cancer therapies.
Its services include blood cancer network, cancer care overview, cardiovascular research, contract research organization, nurse navigators, oncology research, personalized medicine, radiation oncology, and site management organization.It offers early oncology drug development in both solid tumors and hematologic malignancies.
SCRI conducts research in the fields of oncology and cardiology.The institute partners with investigators and pharmaceutical and biotech companies to conduct clinical trials.
It has operations in Austin, Dallas, Denver, Kansa City, London, Nashville, North Florida, Richmond, and San Antonio, the US. SCRI is headquarters in Nashville, Tennessee, the US.
Sarah Cannon Research Institute LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings.The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period.
The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope - Financial Deals - Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company’s operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company.
Reasons to Buy Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements - The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy - The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Our reports have been used by over 10K customers, including:
Left Ventricular Dysfunction - Pipeline Review, H2 2019 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Left Ventricular Dysfunction - Pipeline Review, H2 2019, provides an overview of the Left Ventricular Dysfunction (Cardiovascular) pipeline landscape. Left...
The Global Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech 2014-2019 report provides a detailed understanding and analysis of how, why and what terms companies enter preclinical stage partnering deals. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization...
Continuous Glucose Monitoring Systems - Medical Devices Pipeline Assessment, 2019 Summary Medical Devices sector report, "Continuous Glucose Monitoring Systems - Medical Devices Pipeline Assessment, 2019", provides an overview of Continuous Glucose Monitoring Systems currently in pipeline stage. The...
Market Overview Increase in the number of surgeries performed globally is the major factor that is contributing to the growth of global inhalation anesthetics market. For instance, according to the annual estimates of Sedana Medical, there were about 4.5 to 7.5 million people ventilated and sedated worldwide in 2017. Furthermore,...
220 pages •
By Asia Market Information & Development Company
• Aug 2019
China’s demand for Insulin has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption...
231 pages •
By Asia Market Information & Development Company
• Aug 2019
China’s demand for Skin Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer...
129 pages •
By Infiniti Research Limited
• Aug 2019
Global Kidney Transplantation Therapeutics Market: About this market This kidney transplantation therapeutics market analysis considers sales from selective cytokine inhibitors, immunosuppressive antimetabolites, and other drugs. Our analysis also considers the sales of kidney transplantation therapeutics in Asia, Europe,...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.